The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.1M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 708K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

18 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
DNA POLYMERASE THETA INHIBITOR AND USE THEREOFBDB
Shanghai Apeiron Therapeutics Company
CLASS OF ALKYLPHENOL COMPOUNDS AND PREPARATION METHOD THEREFORBDB
Shanghai Institute of Materia Medica
NEW BENZODIAZEPINE DERIVATIVES AS GABA A GAMMA1 PAMBDB
Hoffmann-La Roche
Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said substituted indazoles, and use of said substituted indazoles to produce drugsBDB
Bayer Pharma Aktiengesellschaft
Modulators of Cystic Fibrosis Transmembrane Conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorsBDB
Vertex Pharmaceuticals
AMIDE COMPOUND, PHARMACEUTICAL COMPOSITION AND USE THEREOFBDB
Artivila (Shenzhen) Innovation Center
PSMA INHIBITOR, COMPOUND AND APPLICATIONBDB
Peking University First Hospital
Radiolabelled MGL pet ligandsBDB
Janssen Pharmaceutica
Sulfonamide derivatives for protein degradationBDB
Dana-Farber Cancer Institute
HALOGENATED-HETEROARYL AND OTHER HETEROCYCLIC KINASE INHIBITORS, AND USES THEREOFBDB
Iomx Therapeutics
Heterocyclic compounds as immunomodulatorsBDB
Incyte
Small molecule inhibitors of neutral sphingomyelinase 2 (nSMase2) for the treatment of neurodegenerative diseasesBDB
The Johns Hopkins University
Inhibitors of protein kinasesBDB
Alexion Pharmaceuticals
Compounds useful for inhibiting RORγtBDB
Eli Lilly
Bicyclic compounds as ATX inhibitorsBDB
Hoffmann-La Roche
Compounds and compositions as protein kinase inhibitorsBDB
Array Biopharma
Tricyclic compounds as inhibitors of mutant IDH enzymesBDB
Merck Sharp & Dohme
Epiblastin A Induces Reprogramming of Epiblast Stem Cells Into Embryonic Stem Cells by Inhibition of Casein Kinase 1.BDB
Max Planck Institute of Molecular Physiology